GGrantIndex
Sort

78,016 grants matching breast cancer

Molecular mechanisms of estrogen receptor-dependent transcription regulation

$548,641
Robert G Roeder · Rockefeller University · R01 · FY2020 · CA

Decisions &Outcomes of BRCA1/2 Test for Breast Patients

$548,606
Georgetown University · R01 · FY2005 · CA

Data Driven Background Estimation in PET

$548,591
Suleman Surti · University Of Pennsylvania · R01 · FY2025 · EB

Synergistic combinatorial DNA damage response/repair inhibition and Sacituzumab Govitecan in triple-negative breast cancer

$548,587
Leif W Ellisen · Massachusetts General Hospital · R01 · FY2023 · CA

FUNCTIONAL ANALYSIS AND THERAPEUTIC POTENTIAL OF MIR-708 IN METASTATIC BREAST CANCER

$548,574
Weill Medical College Of Cornell University · · FY2013 · Department of Defense

Brain-selective estrogen therapy for menopausal hot flushes in an advanced translational animal model

$548,544
Istvan Jozsef Merchenthaler · University Of Maryland Baltimore · R01 · FY2025 · AG

Translating Unique Learning for Incontinence Prevention: The TULIP Project

$548,464
Carolyn M Sampselle · University Of Michigan At Ann Arbor · R01 · FY2012 · NR

Regulation of Fibroblast Phenotype in Lung Fibrosis

$548,433
James S Hagood · University Of California, San Diego · R01 · FY2015 · HL

Development of Mechanism-based Strategies for the Treatment of AdvancedBreast C

$548,363
Neal Rosen · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA

MicroRNA profiles of TN breast cancer to define subgroups and targets for therapy

$548,311
Kay Huebner · Ohio State University · U01 · FY2010 · CA

Functional, cellular, and molecular imaging and therapy monitoring using ultrasou

$548,276
Stanislav Y Emelianov · University Of Texas At Austin · R01 · FY2014 · CA

Genomic and Transcriptomic Analysis of Breast and Ovarian Cancers

$548,271
Joellen M. Schildkraut · Emory University · R01 · FY2022 · CA

Case Control Study of Pancreas Cancer in Shanghai, China

$548,262
Harvey A Risch · Yale University · R01 · FY2007 · CA

Next-Generation Whole-Body MRI for Detection and Assessment of Therapy Response in Bone Lesions

$548,249
Ananth J Madhuranthakam · Ut Southwestern Medical Center · R01 · FY2023 · CA

AN EPIGENETIC REGULATORY HUB IN TRIPLE-NEGATIVE BREAST CANCER

$548,247
Case Western Reserve University · · FY2014 · Department of Defense

Chemical, structural and molecular rules for fully antagonizing the estrogen receptor

$548,236
Kendall W Nettles · University Of Florida · R01 · FY2022 · CA

Obesity, chemotherapy dosing, and breast cancer outcomes

$548,185
Elizabeth David Kantor · Sloan-Kettering Inst Can Research · R37 · FY2018 · CA

INCREASING SCREENING ADHERENCE THROUGH A PHYSICIAN TRIAL

$548,179
University Of California Los Angeles · R01 · FY2003 · CA

Chemotherapy-induced circadian master clock disruptions and fatigue

$548,150
Leah M Pyter · Ohio State University · R01 · FY2023 · CA

NEW MEXICO MAMMOGRAPHY PROJECT

$548,141
University Of New Mexico · U01 · FY2001 · CA

ProstaFluor FDA Trial for Real-Time Margin Detection During Prostatectomy

$548,085
David A. Benaron · Spectros Corporation · R01 · FY2014 · CA

Behavioral and Psychological Impact of Returning Breast Density Results to Latinas

$548,082
Carmen Radecki Breitkopf · Mayo Clinic Rochester · R01 · FY2018 · MD

Biomarkers for Staging and Treatment Response Monitoring of Bladder Cancer

$548,074
Lubomir M Hadjiyski · University Of Michigan At Ann Arbor · U01 · FY2017 · CA

Mechanical Regulation of Tumor Angiogenesis

$548,069
Cynthia A Reinhart-King · Vanderbilt University · R01 · FY2017 · HL

Molecular Imaging and Targeted Therapy of HER2-Positive Breast Cancers

$548,064
Jacek Capala · Basic Sciences · Z01 · FY2007 · CA